Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 mutations acquired in mink reduce antibody-mediated neutralization
Markus Hoffmann, Lu Zhang, Nadine Krüger, et al.
Cell Reports (2021) Vol. 35, Iss. 3, pp. 109017-109017
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic
Markus Hoffmann, Nadine Krüger, Sebastian Schulz, et al.
Cell (2021) Vol. 185, Iss. 3, pp. 447-456.e11
Open Access | Times Cited: 869
Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants
Amarendra Pegu, Sarah O’Connell, Stephen D. Schmidt, et al.
Science (2021) Vol. 373, Iss. 6561, pp. 1372-1377
Open Access | Times Cited: 541
SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity
Chihiro Motozono, Mako Toyoda, Jiří Zahradník, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 7, pp. 1124-1136.e11
Open Access | Times Cited: 519
Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7
Bo Meng, Steven A. Kemp, Guido Papa, et al.
Cell Reports (2021) Vol. 35, Iss. 13, pp. 109292-109292
Open Access | Times Cited: 412
After the pandemic: perspectives on the future trajectory of COVID-19
Amalio Telenti, Ann M. Arvin, Lawrence Corey, et al.
Nature (2021) Vol. 596, Iss. 7873, pp. 495-504
Open Access | Times Cited: 389
SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination
Markus Hoffmann, Heike Hofmann-Winkler, Nadine Krüger, et al.
Cell Reports (2021) Vol. 36, Iss. 3, pp. 109415-109415
Open Access | Times Cited: 232
SARS-CoV-2 one year on: evidence for ongoing viral adaptation
Thomas P. Peacock, Rebekah Penrice-Randal, Julian A. Hiscox, et al.
Journal of General Virology (2021) Vol. 102, Iss. 4
Open Access | Times Cited: 166
Neutralising antibody escape of SARS‐CoV‐2 spike protein: Risk assessment for antibody‐based Covid‐19 therapeutics and vaccines
Daniele Focosi, Fabrizio Maggi
Reviews in Medical Virology (2021) Vol. 31, Iss. 6
Open Access | Times Cited: 161
A core-shell structured COVID-19 mRNA vaccine with favorable biodistribution pattern and promising immunity
Ren Yang, Yao Deng, Baoying Huang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 106
The Remarkable Evolutionary Plasticity of Coronaviruses by Mutation and Recombination: Insights for the COVID-19 Pandemic and the Future Evolutionary Paths of SARS-CoV-2
Grigoris D. Amoutzias, Marios Nikolaidis, Eleni Tryfonopoulou, et al.
Viruses (2022) Vol. 14, Iss. 1, pp. 78-78
Open Access | Times Cited: 82
SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency
Lu Zhang, Amy Kempf, Inga Nehlmeier, et al.
Cell (2024) Vol. 187, Iss. 3, pp. 596-608.e17
Closed Access | Times Cited: 71
Evolution and neutralization escape of the SARS-CoV-2 BA.2.86 subvariant
Khadija Khan, Gila Lustig, Cornelius Römer, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 70
TMPRSS2 Is Essential for SARS-CoV-2 Beta and Omicron Infection
Kristin Metzdorf, Henning Jacobsen, Marina C. Greweling‐Pils, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 271-271
Open Access | Times Cited: 43
Natural and Experimental SARS-CoV-2 Infection in Domestic and Wild Animals
David A. Meekins, Natasha N. Gaudreault, Jüergen A. Richt
Viruses (2021) Vol. 13, Iss. 10, pp. 1993-1993
Open Access | Times Cited: 94
SARS-CoV-2 variant B.1.617 is resistant to Bamlanivimab and evades antibodies induced by infection and vaccination
Markus Hoffmann, Heike Hofmann-Winkler, Nadine Krüger, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 90
Emerging SARS-CoV-2 Variants: Genetic Variability and Clinical Implications
Aakriti Dubey, Shweta Choudhary, Pravindra Kumar, et al.
Current Microbiology (2021) Vol. 79, Iss. 1
Open Access | Times Cited: 71
The Omicron variant is highly resistant against antibody-mediated neutralization – implications for control of the COVID-19 pandemic
Markus Hoffmann, Nadine Krüger, Sebastian Schulz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 64
Zoonotic and Reverse Zoonotic Transmissibility of SARS-CoV-2
Iryna V. Goraichuk, Vasiliy L. Arefiev, B. Т. Stegniy, et al.
Virus Research (2021) Vol. 302, pp. 198473-198473
Open Access | Times Cited: 60
Mutation Y453F in the spike protein of SARS-CoV-2 enhances interaction with the mink ACE2 receptor for host adaption
Wenlin Ren, Jun Lan, Xiaohui Ju, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 11, pp. e1010053-e1010053
Open Access | Times Cited: 56
Mutations that adapt SARS-CoV-2 to mink or ferret do not increase fitness in the human airway
Jie Zhou, Thomas P. Peacock, Jonathan C. Brown, et al.
Cell Reports (2022) Vol. 38, Iss. 6, pp. 110344-110344
Open Access | Times Cited: 56
SARS-CoV-2 Omicron sublineages show comparable cell entry but differential neutralization by therapeutic antibodies
Prerna Arora, Lu Zhang, Nadine Krüger, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 8, pp. 1103-1111.e6
Open Access | Times Cited: 45
Variability in the Clinical Course of COVID-19 in a Retrospective Analysis of a Large Real-World Database
Robert Flisiak, Piotr Rzymski, Dorota Zarębska‐Michaluk, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 149-149
Open Access | Times Cited: 38
Animal Models, Zoonotic Reservoirs, and Cross-Species Transmission of Emerging Human-Infecting Coronaviruses
Yakhouba Kane, Gary Wong, George F. Gao
Annual Review of Animal Biosciences (2023) Vol. 11, Iss. 1, pp. 1-31
Open Access | Times Cited: 23
Evolutionary rate of SARS-CoV-2 increases during zoonotic infection of farmed mink
Ashleigh F. Porter, Damian F. J. Purcell, Benjamin P. Howden, et al.
Virus Evolution (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 22
Rapid spread of the SARS-CoV-2 JN.1 lineage is associated with increased neutralization evasion
Lu Zhang, Alexandra Dopfer-Jablonka, Anne Cossmann, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109904-109904
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top